Accuracy of drug hepatotoxicity potential classifications in assessing severity related to drug-induced liver injury (dili)

被引:0
|
作者
Sanz-Villanueva, L. [1 ,2 ]
Parra-Martinez, C. [1 ,2 ]
Medina-Caliz, I. [1 ,2 ]
Sanabria-Cabrera, J. [1 ,2 ]
Robles-Diaz, M. [1 ,2 ]
Ortega-Alonso, A. [1 ,2 ]
Gonzalez-Jimenez, A. [3 ,4 ]
Gasca, J. [1 ,2 ]
Sanjuan-Jimenez, R. [1 ,2 ]
Garcia-Cortes, M. [1 ,2 ]
Lucena, M. I. [1 ,2 ]
Andrade, R. J. [1 ,2 ]
机构
[1] Univ Malaga, Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, CIBERehd,UGC Aparato Digest, Malaga, Spain
[2] Univ Malaga, Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, CIBERehd,Serv Farmacol Clin, Malaga, Spain
[3] Univ Malaga, Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, UGC Aparato Digest, Malaga, Spain
[4] Univ Malaga, Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, Serv Farmacol Clin, Malaga, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
EACPT-1366
引用
收藏
页码:S103 / S103
页数:1
相关论文
共 50 条
  • [21] Drug-induced liver injury (DILI) in an Asian tertiary referral centre
    Tan, H-H
    Ang, J-A
    Kumaran, S. S.
    Chow, W-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 161 - 161
  • [22] Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
    Mullins, Caitlin
    Beaulac, Kirthana
    Sylvia, Lynne
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (06) : 526 - 532
  • [23] Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
    Guillermo Quintás
    Teresa Martínez-Sena
    Isabel Conde
    Eugenia Pareja Ibars
    Jos Kleinjans
    José V. Castell
    Archives of Toxicology, 2021, 95 : 3049 - 3062
  • [24] Drug-induced Liver Injury (DILI) from Initial Dose of Infliximab
    Cheng, Fong-Kuei
    Bridges, Edward
    Betteridge, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S424 - S425
  • [25] Assessing causality in drug-induced liver injury
    Lee, WM
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1003 - 1005
  • [26] Drug-Induced Liver Injury (DILI) Does Not Always Follow the Textbook
    Ajayi, Teminioluwa A.
    Dawodu, Ejemenare A.
    Huh, Won J.
    Scanga, Andrew E.
    Izzy, Manhal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1312 - S1313
  • [27] Risk factors for chronicity in idiosyncratic drug-induced liver injury (DILI)
    Medina-Caliz, I.
    Garcia-Munoz, B.
    Diaz, Mercedes Robles
    Stephens, C.
    Gonzalez-Jimenez, Andres
    Garcia-Cortes, Miren
    Ortega, A.
    Hidalgo, Ramon
    Fernandez, Maria Carmen
    Romero-Gomez, Manuel
    Navarro, J. M.
    Hallal, Hacibe
    Planas, Ramon
    Avila, S.
    Blanco, S.
    Castiella, Agustin
    Zapata, E.
    Jimenez, Miguel
    Moreno-Planas, J. M.
    Sori-Ano, German
    Guarner, Carlos
    Roman, E.
    Primo, Joaquin
    Aldea, A.
    Prieto, Martin
    Lucena, M. I.
    Andrade, Raul J.
    HEPATOLOGY, 2014, 60 : 713A - 714A
  • [28] Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic
    Moreno, Luis
    Sanchez-Delgado, Jordi
    Vergara, Mercedes
    Casas, Meritxell
    Miquel, Mireia
    Dalmau, Blai
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (12) : 767 - 768
  • [29] Biomarkers of idiosyncratic drug-induced liver injury (DILI)-a systematic review
    Atallah, Edmond
    Freixo, Cristiana
    Alvarez-Alvarez, Ismael
    Cubero, F. J.
    Gerbes, Alexander L.
    Kullak-Ublick, Gerd A.
    Aithal, Guruprasad P.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (11) : 1327 - 1343
  • [30] Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
    Quintas, Guillermo
    Martinez-Sena, Teresa
    Conde, Isabel
    Pareja Ibars, Eugenia
    Kleinjans, Jos
    Castell, Jose, V
    ARCHIVES OF TOXICOLOGY, 2021, 95 (09) : 3049 - 3062